Ovarian Cancer Research Institute
Overview
The Ovarian Cancer Research Institute is dedicated to advancing scientific research and treatments specifically focused on ovarian cancer. With a commitment to improving patient outcomes, the institute supports research initiatives and fosters collaborations to further understanding of this critical health issue.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Ovarian Cancer Research Institute in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
3BMS Australia Pty Ltd
Australia
Novotech Health Holdings
Australia
Rhythm Biosciences Limited
Australia
11 Battalion Medical Technology Co., Ltd
China
150 Cophavina Pharmaceutical One Member Company Limited
Vietnam
24cedo S.A.
Argentina
3D Imaging Drug Design and Development LLC
United States
3D Medicines Inc.
China
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.